These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 24941081)

  • 1. Loss-of-function mutations in APOC3, triglycerides, and coronary disease.
    ; Crosby J; Peloso GM; Auer PL; Crosslin DR; Stitziel NO; Lange LA; Lu Y; Tang ZZ; Zhang H; Hindy G; Masca N; Stirrups K; Kanoni S; Do R; Jun G; Hu Y; Kang HM; Xue C; Goel A; Farrall M; Duga S; Merlini PA; Asselta R; Girelli D; Olivieri O; Martinelli N; Yin W; Reilly D; Speliotes E; Fox CS; Hveem K; Holmen OL; Nikpay M; Farlow DN; Assimes TL; Franceschini N; Robinson J; North KE; Martin LW; DePristo M; Gupta N; Escher SA; Jansson JH; Van Zuydam N; Palmer CN; Wareham N; Koch W; Meitinger T; Peters A; Lieb W; Erbel R; Konig IR; Kruppa J; Degenhardt F; Gottesman O; Bottinger EP; O'Donnell CJ; Psaty BM; Ballantyne CM; Abecasis G; Ordovas JM; Melander O; Watkins H; Orho-Melander M; Ardissino D; Loos RJ; McPherson R; Willer CJ; Erdmann J; Hall AS; Samani NJ; Deloukas P; Schunkert H; Wilson JG; Kooperberg C; Rich SS; Tracy RP; Lin DY; Altshuler D; Gabriel S; Nickerson DA; Jarvik GP; Cupples LA; Reiner AP; Boerwinkle E; Kathiresan S
    N Engl J Med; 2014 Jul; 371(1):22-31. PubMed ID: 24941081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.
    Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
    N Engl J Med; 2014 Jul; 371(1):32-41. PubMed ID: 24941082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivating mutations in NPC1L1 and protection from coronary heart disease.
    ; Stitziel NO; Won HH; Morrison AC; Peloso GM; Do R; Lange LA; Fontanillas P; Gupta N; Duga S; Goel A; Farrall M; Saleheen D; Ferrario P; König I; Asselta R; Merlini PA; Marziliano N; Notarangelo MF; Schick U; Auer P; Assimes TL; Reilly M; Wilensky R; Rader DJ; Hovingh GK; Meitinger T; Kessler T; Kastrati A; Laugwitz KL; Siscovick D; Rotter JI; Hazen SL; Tracy R; Cresci S; Spertus J; Jackson R; Schwartz SM; Natarajan P; Crosby J; Muzny D; Ballantyne C; Rich SS; O'Donnell CJ; Abecasis G; Sunaev S; Nickerson DA; Buring JE; Ridker PM; Chasman DI; Austin E; Kullo IJ; Weeke PE; Shaffer CM; Bastarache LA; Denny JC; Roden DM; Palmer C; Deloukas P; Lin DY; Tang ZZ; Erdmann J; Schunkert H; Danesh J; Marrugat J; Elosua R; Ardissino D; McPherson R; Watkins H; Reiner AP; Wilson JG; Altshuler D; Gibbs RA; Lander ES; Boerwinkle E; Gabriel S; Kathiresan S
    N Engl J Med; 2014 Nov; 371(22):2072-82. PubMed ID: 25390462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An APOC3 3'UTR variant associated with plasma triglycerides levels and coronary heart disease by creating a functional miR-4271 binding site.
    Hu SL; Cui GL; Huang J; Jiang JG; Wang DW
    Sci Rep; 2016 Sep; 6():32700. PubMed ID: 27624799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.
    Khetarpal SA; Zeng X; Millar JS; Vitali C; Somasundara AVH; Zanoni P; Landro JA; Barucci N; Zavadoski WJ; Sun Z; de Haard H; Toth IV; Peloso GM; Natarajan P; Cuchel M; Lund-Katz S; Phillips MC; Tall AR; Kathiresan S; DaSilva-Jardine P; Yates NA; Rader DJ
    Nat Med; 2017 Sep; 23(9):1086-1094. PubMed ID: 28825717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.
    Pollin TI; Damcott CM; Shen H; Ott SH; Shelton J; Horenstein RB; Post W; McLenithan JC; Bielak LF; Peyser PA; Mitchell BD; Miller M; O'Connell JR; Shuldiner AR
    Science; 2008 Dec; 322(5908):1702-5. PubMed ID: 19074352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity.
    Saleheen D; Natarajan P; Armean IM; Zhao W; Rasheed A; Khetarpal SA; Won HH; Karczewski KJ; O'Donnell-Luria AH; Samocha KE; Weisburd B; Gupta N; Zaidi M; Samuel M; Imran A; Abbas S; Majeed F; Ishaq M; Akhtar S; Trindade K; Mucksavage M; Qamar N; Zaman KS; Yaqoob Z; Saghir T; Rizvi SNH; Memon A; Hayyat Mallick N; Ishaq M; Rasheed SZ; Memon FU; Mahmood K; Ahmed N; Do R; Krauss RM; MacArthur DG; Gabriel S; Lander ES; Daly MJ; Frossard P; Danesh J; Rader DJ; Kathiresan S
    Nature; 2017 Apr; 544(7649):235-239. PubMed ID: 28406212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups.
    Goyal S; Tanigawa Y; Zhang W; Chai JF; Almeida M; Sim X; Lerner M; Chainakul J; Ramiu JG; Seraphin C; Apple B; Vaughan A; Muniu J; Peralta J; Lehman DM; Ralhan S; Wander GS; Singh JR; Mehra NK; Sidorov E; Peyton MD; Blackett PR; Curran JE; Tai ES; van Dam R; Cheng CY; Duggirala R; Blangero J; Chambers JC; Sabanayagam C; Kooner JS; Rivas MA; Aston CE; Sanghera DK
    Lipids Health Dis; 2021 Sep; 20(1):113. PubMed ID: 34548093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
    Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
    Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutations of APOC3 gene, metabolism of triglycerides and reduction of ischemic cardiovascular events].
    Pirillo A; Catapano AL
    G Ital Cardiol (Rome); 2015 May; 16(5):289-94. PubMed ID: 25994465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
    Petersen KF; Dufour S; Hariri A; Nelson-Williams C; Foo JN; Zhang XM; Dziura J; Lifton RP; Shulman GI
    N Engl J Med; 2010 Mar; 362(12):1082-9. PubMed ID: 20335584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and phenotype consequence of APOC3 rare variants in patients with very low triglyceride levels.
    Crawford DC; Restrepo NA; Diggins KE; Farber-Eger E; Wells QS
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):66. PubMed ID: 30255797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOC3, coronary disease, and complexities of Mendelian randomization.
    Cohen JC; Stender S; Hobbs HH
    Cell Metab; 2014 Sep; 20(3):387-9. PubMed ID: 25185943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOC3 mutation, serum triglyceride concentrations, and coronary heart disease.
    Tsai MY; Ordovas JM
    Clin Chem; 2009 Jul; 55(7):1274-6. PubMed ID: 19443564
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.
    Kozlitina J; Boerwinkle E; Cohen JC; Hobbs HH
    Hepatology; 2011 Feb; 53(2):467-74. PubMed ID: 21274868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic exercise reduces triglycerides by targeting apolipoprotein C3 in patients with coronary heart disease.
    Wang Y; Shen L; Xu D
    Clin Cardiol; 2019 Jan; 42(1):56-61. PubMed ID: 30511426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes.
    Dorfmeister B; Cooper JA; Stephens JW; Ireland H; Hurel SJ; Humphries SE; Talmud PJ
    Biochim Biophys Acta; 2007 Mar; 1772(3):355-63. PubMed ID: 17197160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable effects of the APOC3-482C > T variant on insulin, glucose and triglyceride concentrations in different ethnic groups.
    Waterworth DM; Talmud PJ; Humphries SE; Wicks PD; Sagnella GA; Strazzullo P; Alberti KG; Cook DG; Cappuccio FP
    Diabetologia; 2001 Feb; 44(2):245-8. PubMed ID: 11270684
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wulff AB; Nordestgaard BG; Tybjærg-Hansen A
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):660-668. PubMed ID: 29348120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.